Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition. Studies ...
Recent progress in oncological pharmacotherapy has resulted in more complex treatment options and adverse event management, widening gaps in care quality between specialised centres and local ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback